Kobayashi Pharmaceutical Co Stock Price To Earnings To Growth
| KBYPFDelisted Stock | USD 32.49 0.00 0.00% |
Kobayashi Pharmaceutical Co fundamentals help investors to digest information that contributes to Kobayashi Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Kobayashi Pink Sheet. The fundamental analysis module provides a way to measure Kobayashi Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kobayashi Pharmaceutical pink sheet.
Kobayashi |
Kobayashi Pharmaceutical Co Company Price To Earnings To Growth Analysis
Kobayashi Pharmaceutical's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Kobayashi Pharmaceutical Co has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Consumer Defensive sector and 100.0% lower than that of the Household & Personal Products industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Kobayashi Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kobayashi Pharmaceutical's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kobayashi Pharmaceutical could also be used in its relative valuation, which is a method of valuing Kobayashi Pharmaceutical by comparing valuation metrics of similar companies.Kobayashi Pharmaceutical is currently under evaluation in price to earnings to growth category among its peers.
Kobayashi Fundamentals
| Return On Equity | 0.0968 | |||
| Return On Asset | 0.0633 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 3.94 B | |||
| Shares Outstanding | 76.01 M | |||
| Shares Owned By Insiders | 34.50 % | |||
| Shares Owned By Institutions | 21.77 % | |||
| Price To Earning | 34.29 X | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 155.25 B | |||
| Gross Profit | 88.77 B | |||
| EBITDA | 32.49 B | |||
| Net Income | 19.71 B | |||
| Cash And Equivalents | 116.15 B | |||
| Total Debt | 596 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 3.92 X | |||
| Book Value Per Share | 2,653 X | |||
| Cash Flow From Operations | 22.42 B | |||
| Earnings Per Share | 1.94 X | |||
| Number Of Employees | 3.45 K | |||
| Beta | 0.27 | |||
| Market Capitalization | 5.37 B | |||
| Total Asset | 252.55 B | |||
| Z Score | 5.4 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 252.55 B | |||
| Last Dividend Paid | 84.0 |
About Kobayashi Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kobayashi Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kobayashi Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kobayashi Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Kobayashi Pink Sheet
If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |